FFC#2/2017

Identification of deubiquitinases and ubiquitin ligases that affect mutant CFTR rescue

FFC#2/2017

Identification of deubiquitinases and ubiquitin ligases that affect mutant CFTR rescue

PRINCIPAL INVESTIGATOR

Luis Galietta (Istituto Telethon di Genetica e Medicina – TIGEM, Napoli)

RESEARCHERS

4

CATEGORY

AREA 1 Therapies to correct the underlying defect

DURATION

2 years

GOAL

€ 90.000 €

RESULTS

Using gene silencing by siRNA transfection, we have identified a panel of DUBs that influence F508del-CFTR rescue by corrector VX-809. In particular, knockdown of USP13 results in decreased F508del-CFTR function. Therefore, these DUBs may have a protective role on F508del-CFTR by contrasting the process of ubiquitination that occurs even in the presence of the corrector. The researchers also found DUBs whose silencing amplifies mutant CFTR rescue. In this case, it needs to postulate a more indirect mechanism in which the DUB activity affects the expression/function of a regulator of F508del-CFTR processing.
A better knowledge of the mechanisms that limit mutant CFTR rescue can lead to improved therapeutic strategies. The research will continue in the project FFC#6/2019.

OTHER RESULTS

FFC #3/2024

Two molecules are effective in activating Heat Shock Proteins and enhancing the action of CFTR correctors with the F508del mutation in vitro.

FFC#5/2024

Some peptide nucleic acids (PNAs) re-sensitise Pseudomonas aeruginosa to the antibiotic meropenem in vitro and reduce its virulence.

FFC#1/2023

Tezacaftor, one of the components of Kaftrio, induces an accumulation of dihydroceramides both in vitro and in vivo in animal models